Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Cancer Immunotherapy Market Shape Industry Trends by 2034?

In recent times, a swift expansion has been observed in the market size of cancer immunotherapy. Predictions suggest growth from $110.91 billion in 2024, escalating to $125.68 billion in 2025, representing a compound annual growth rate (CAGR) of 13.3%. Aspects contributing to growth during this historic period include the increasing incidence of cancer, growing preference for immunotherapy over conventional therapy, escalating research and development operations for targeted diseases, improvements in the effectiveness and precision of new therapies, and an expanding awareness of the shortcomings of traditional cancer treatments.

Expectations are set for the cancer immunotherapy market to witness a significant expansion in the coming years, with predictions indicating growth to $194.64 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.6%. The upswing predicted within the forecast period is associated with increasing endorsements of innovative cancer immunotherapies, surge in the demand for personalized medical treatments, growing number of individuals diagnosed with cancer, improved investment in clinical research for advanced treatment methods, and increasing public awareness of cancer immunotherapy. Anticipated trends in the forecast period are inclusive of the rise of adoptive cell therapies such as car-t cells, exploration into the use of oncolytic viruses in cancer immunotherapy, advancements in customised cancer vaccines, incorporation of artificial intelligence in researching immunotherapy, and heightened focus on real-world evidence and patient outcomes in making treatment decisions.

What Major Innovations Are Driving the Accelerated Growth of the cancer immunotherapy Market?

The anticipated surge in cancer occurrences is predicted to drive the cancer immunotherapy market. The escalating rates of cancer worldwide can be attributed to various factors such as tobacco use, alcohol consumption, obesity, inactive lifestyle, and environmental influences. This surge in cancer diagnoses is likely to stimulate the demand for cancer immunotherapy, given that patients are progressively investing in treatment procedures that offer higher survival chances and lesser discomfort. For example, the European Union Science Hub, a Belgium-based Joint Research Centre of the European Commission, reported in October 2023 that new cancer cases saw a 2.3% rise over the previous two years, amounting to 2.74 million in 2022. Cancer-related deaths also saw a hike of 2.4% during the same time frame. Consequently, this rise in cancer prevalence is projected to escalate the demand for cancer immunotherapy in the forecasted period.

Get Your Free Sample of the Global Cancer Immunotherapy Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp

Who Are the Key Market Players Influencing the Growth of the Cancer Immunotherapy Industry?

Major companies operating in the cancer immunotherapy market include:

• Amgen Inc._x000D_

• AstraZeneca PLC_x000D_

• F. Hoffmann-La Roche Ltd_x000D_

• Bayer AG_x000D_

• Eli Lilly and Company_x000D_

What Key Market Trends Are Shaping the Future of the Cancer Immunotherapy Industry?

The cancer immunotherapy market is witnessing a growing trend of leveraging advanced technologies. These innovative technologies, including immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy, are being used in various therapies to enable the immune system to detect and combat tumors. Such integration of technologies is revolutionizing cancer treatment and recovery. For instance, in October 2022, AstraZeneca plc, a leading pharmaceutical and biotechnology company based in the UK, received authorization for the use of Capivasertib, in conjunction with Faslodex. This cancer immunotherapeutic drug, which is utilized in the treatment of breast cancer, has proven effective when used after recurrence or progression on or after endocrine therapy. It is particularly beneficial for locally advanced or metastatic breast cancer patients with low or negative human epidermal growth factor receptor 2 (HER2).

Get Instant Access to the Global Cancer Immunotherapy Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report

What Are the Main Segments of the Cancer Immunotherapy Market, and How Are They Evolving?

The cancer immunotherapy market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

3) By End User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

4) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

Which Regions Are Emerging as Leaders in the Cancer Immunotherapy Market?

North America was the largest region in the cancer immunotherapy market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Defining Features of the Cancer Immunotherapy Market?

Cancer immunotherapy refers to a type of cancer therapy that strengthens your body’s defenses against the disease. Your body’s immune system aids in the defense against infections and other disorders. White blood cells, organs, and lymphatic system tissues make up this substance. Cancer immunotherapy comes in various forms, such as cytokines and vaccines, adoptive cell therapies, oncolytic viruses, tumor-infecting viruses, and others.

Browse Through More Similar Reports By The Business Research Company:

Lung Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

Metabolomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: